JP2018532814A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532814A5
JP2018532814A5 JP2018543300A JP2018543300A JP2018532814A5 JP 2018532814 A5 JP2018532814 A5 JP 2018532814A5 JP 2018543300 A JP2018543300 A JP 2018543300A JP 2018543300 A JP2018543300 A JP 2018543300A JP 2018532814 A5 JP2018532814 A5 JP 2018532814A5
Authority
JP
Japan
Prior art keywords
subject
composition
pharmaceutical
medicament
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018543300A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532814A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/061247 external-priority patent/WO2017083470A1/en
Publication of JP2018532814A publication Critical patent/JP2018532814A/ja
Publication of JP2018532814A5 publication Critical patent/JP2018532814A5/ja
Priority to JP2022176288A priority Critical patent/JP2023011830A/ja
Priority to JP2024231683A priority patent/JP2025068627A/ja
Pending legal-status Critical Current

Links

JP2018543300A 2015-11-10 2016-11-10 細胞の酸化還元レベルの制御 Pending JP2018532814A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022176288A JP2023011830A (ja) 2015-11-10 2022-11-02 細胞の酸化還元レベルの制御
JP2024231683A JP2025068627A (ja) 2015-11-10 2024-12-27 細胞の酸化還元レベルの制御

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562253542P 2015-11-10 2015-11-10
US62/253,542 2015-11-10
PCT/US2016/061247 WO2017083470A1 (en) 2015-11-10 2016-11-10 Control of cellular redox levels

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022176288A Division JP2023011830A (ja) 2015-11-10 2022-11-02 細胞の酸化還元レベルの制御

Publications (2)

Publication Number Publication Date
JP2018532814A JP2018532814A (ja) 2018-11-08
JP2018532814A5 true JP2018532814A5 (cg-RX-API-DMAC7.html) 2019-12-19

Family

ID=57530816

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018543300A Pending JP2018532814A (ja) 2015-11-10 2016-11-10 細胞の酸化還元レベルの制御
JP2022176288A Pending JP2023011830A (ja) 2015-11-10 2022-11-02 細胞の酸化還元レベルの制御
JP2024231683A Pending JP2025068627A (ja) 2015-11-10 2024-12-27 細胞の酸化還元レベルの制御

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022176288A Pending JP2023011830A (ja) 2015-11-10 2022-11-02 細胞の酸化還元レベルの制御
JP2024231683A Pending JP2025068627A (ja) 2015-11-10 2024-12-27 細胞の酸化還元レベルの制御

Country Status (14)

Country Link
EP (1) EP3373943A1 (cg-RX-API-DMAC7.html)
JP (3) JP2018532814A (cg-RX-API-DMAC7.html)
CN (1) CN108430482A (cg-RX-API-DMAC7.html)
AR (1) AR106660A1 (cg-RX-API-DMAC7.html)
AU (2) AU2016352986A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018009437A2 (cg-RX-API-DMAC7.html)
CA (1) CA3004951A1 (cg-RX-API-DMAC7.html)
EA (1) EA201891142A1 (cg-RX-API-DMAC7.html)
HK (1) HK1252018A1 (cg-RX-API-DMAC7.html)
IL (1) IL259228B2 (cg-RX-API-DMAC7.html)
MX (1) MX2018005745A (cg-RX-API-DMAC7.html)
MY (1) MY203642A (cg-RX-API-DMAC7.html)
SG (2) SG10202112466UA (cg-RX-API-DMAC7.html)
WO (1) WO2017083470A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110468061B (zh) * 2018-05-11 2024-03-08 韩国亿诺生物有限公司 具有预防或治疗癌症的效果的新型菌株
CN108949640B (zh) * 2018-08-22 2020-08-04 江南大学 短双歧杆菌ccfm1025、其发酵食品及其应用
CN109568320A (zh) * 2018-12-13 2019-04-05 中国人民解放军总医院 依曲韦林在制备抗菌消炎药物中的应用
CN109912598B (zh) * 2019-03-27 2022-09-13 四川大学华西医院 防治炎症反应的核苷类衍生物及其应用
CN110106111B (zh) * 2019-05-06 2021-04-02 华东理工大学 一种假单胞菌制剂的制备方法、制剂产品及其应用
JP7369992B2 (ja) * 2019-05-13 2023-10-27 株式会社明治 自律神経機能改善用の発酵乳
CN110079485B (zh) * 2019-05-31 2020-09-25 江南大学 缓解抑郁的乳酸片球菌ccfm6432、其发酵食品及其应用
US11028264B2 (en) 2019-08-05 2021-06-08 International Business Machines Corporation Polylysine polymers with antimicrobial and/or anticancer activity
WO2021024054A1 (en) * 2019-08-05 2021-02-11 International Business Machines Corporation Combination therapy to achieve enhanced antimicrobial activity
CN110604098B (zh) * 2019-09-23 2021-09-07 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种类风湿关节炎合并间质性肺病动物模型的构建方法
US12569481B2 (en) 2020-06-12 2026-03-10 Vanderbilt University Methods of treatment for gastrointestinal motility disorders
CN111849805B (zh) * 2020-06-17 2022-04-22 天津科技大学 一种具有抗宫颈癌作用的乳酸片球菌及应用
US12383547B2 (en) 2020-07-01 2025-08-12 Vanderbilt University Methods of treatment for a kidney disease
CN117377480A (zh) * 2020-10-14 2024-01-09 音芙医药科技(上海)有限公司 烟酰胺单核苷酸与发酵乳杆菌联合在制备缓解皮肤光老化制剂中的应用
CN113304155B (zh) * 2021-05-24 2023-03-24 四川大学华西医院 一种抗肿瘤的药物组合物及其制备方法和用途
RS68282B1 (en) * 2021-07-09 2026-07-31 Simone Claudio De SPECIES, STRAINS AND COMPOSITIONS OF LACTIC ACID BACTERIA CAPABLE OF MODULATING BODY OXYGENATION BY INCREASE HIF-1ALPHA LEVELS
CN113528399B (zh) * 2021-08-18 2023-02-10 兰州大学 一种具有六价铬离子还原能力的乳酸片球菌及用途
CN113712953B (zh) * 2021-10-20 2022-07-29 济宁医学院附属医院 一种用于骨质疏松性骨折快速愈合的药物组合物
CN114381398B (zh) * 2022-01-08 2022-06-14 浙江大学 具有改善酒精性肝病的瑞士乳杆菌zjuids12及其应用
CN115282151B (zh) * 2022-08-23 2023-06-09 黑龙江护理高等专科学校 一种拉米替隆的应用
CN116042490B (zh) * 2023-03-03 2023-09-01 善恩康生物科技(苏州)有限公司 一种用于抗疲劳、提高运动能力的复合益生菌及制备方法和应用
CN116286669B (zh) * 2023-03-23 2023-09-22 江南大学 一株分泌托拉塞米单克隆抗体的杂交瘤细胞株及其应用
EP4438050A1 (en) * 2023-03-31 2024-10-02 Igen Biolab Group AG Postbiotic composition comprising bacterial lysates for oral administration for treating solid tumors
CN121013725A (zh) * 2023-03-31 2025-11-25 西格尼弗有限责任公司 用于治疗实体瘤包含细菌裂解物的口服后生元组合物
EP4527398A1 (en) * 2023-09-22 2025-03-26 Igen Biolab Group AG Therapeutic use of a postbiotic composition in colon and or lung cancer
CN116735756A (zh) * 2023-08-08 2023-09-12 天津辰欣药物研究有限公司 一种气相色谱法测定佩玛贝特起始物料中3-溴丙胺氢溴酸盐杂质的检测方法
CN117462557B (zh) * 2023-09-26 2026-05-01 大连医科大学附属第一医院 伐尼克兰在制备抗生素增强剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202013014RA (en) * 2012-01-16 2021-02-25 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
JP6670244B2 (ja) * 2014-01-07 2020-03-18 バビタ アグラワル 免疫調節組成物及びその使用法

Similar Documents

Publication Publication Date Title
EP2613797B1 (en) Compositions and methods for the removal of biofilms
CA2988686C (en) Compositions comprising bacterial strains
JP2023011830A (ja) 細胞の酸化還元レベルの制御
CA2988661A1 (en) Compositions comprising bacterial strains
HRP20191533T1 (hr) Kombinacija lijekova za melanom koja obuhvaća primjenu kobimetiniba i vemurafeniba
JP2015519330A5 (cg-RX-API-DMAC7.html)
PT1587542E (pt) Utilização de anticorpos anti-cd100
CN113329771A (zh) 治疗炎症性和自身免疫性疾病的组合物和方法
KR20210134927A (ko) 화농성 한선염의 치료를 위한 항-il-알파 항체
WO2021195703A1 (en) Combination therapy for inflammatory bowel disease
WO2015027071A1 (en) Gpr81 agonists and methods thereof for promoting production of secretory iga
US20150374718A1 (en) Zhankuic Acid A and Analogs thereof and Their Use as an Anti-Inflammatory Agent
EP4048237B1 (en) Treatment of inflammatory condition in mucous membrane or skin with low amounts of propylene glycol
JP2016515602A (ja) Ibdの治療に使用するためのミルテホシンまたはペリホシン
JP2023553956A (ja) 関節の炎症性障害のための併用療法
Buch et al. Systemic sclerosis: C. treatment and assessment
HK40059206A (en) Compositions comprising bacterial strains
HK40025556A (en) Compositions comprising bacterial strains
JP2022505313A (ja) 慢性腎疾患随伴掻痒を処置する方法及びデバイス
HK1260125A1 (en) Compositions comprising bacterial strains
Rashid et al. New Non-anti-TNF-α Biological
HK40047985A (en) Use of gram negative species to treat atopic dermatitis
Hammer Modulation of the OGF-OGFr axis alters the disease course of relapse remitting experimental autoimmune encephalomyelitis
JPWO1997024130A1 (ja) ストレプトコッカス・アガラクチャーIa型あるいはIb型表面多糖を主成分とするガン転移阻害剤
KR20150035495A (ko) 화농성 비부비동염 치료를 위한 티모신 알파의 용도